Summary Basis of Decision in context.
作者信息
Gorman Diane
出版信息
CMAJ. 2005 Jun 21;172(13):1664; author reply 1664-5. doi: 10.1503/cmaj.1041766.
Abstract
摘要
相似文献
1
Summary Basis of Decision in context.
CMAJ. 2005 Jun 21;172(13):1664; author reply 1664-5. doi: 10.1503/cmaj.1041766.
2
Lawsuits anticipated on generic biologicals front.
Nat Biotechnol. 2003 Jul;21(7):721-2. doi: 10.1038/nbt0703-721.
3
Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.
Food Drug Law J. 2006;61(2):273-7.
4
Regulatory watch: impact of PDUFA on regulatory decision-making.
Nat Rev Drug Discov. 2010 Aug;9(8):585. doi: 10.1038/nrd3247.
5
Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
Food Drug Law J. 1998;53(1):123-32.
6
FDA to steer nanotech.
Nat Biotechnol. 2008 Oct;26(10):1060. doi: 10.1038/nbt1008-1060a.
7
The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
Food Drug Law J. 2005;60(2):261-338.
8
Trouble at the office.
Nat Biotechnol. 2008 Sep;26(9):967-9. doi: 10.1038/nbt0908-967.
9
Genta sued over NDA withdrawal.
Nat Biotechnol. 2004 Jul;22(7):788-9. doi: 10.1038/nbt0704-788.
10
The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
Healthspan. 1992 Dec;9(11):12-4.
本文引用的文献
1
Transparency in drug regulation: mirage or oasis?
CMAJ. 2004 Nov 23;171(11):1363-5. doi: 10.1503/cmaj.1041446.
Zotero 插件